IP Library › Assignment 052758/0220
Patent Assignment
Reel/Frame 052758/0220

Assignment of Assignor's Interest

Recorded: 2020-05-27 Pages: 6
Assignor
SESEN BIO, INC.
Executed: 2019-02-14
Assignee
BUZZARD PHARMACEUTICALS AB
KAROLINSKA SCIENCE PARK, FOGDEVRETEN 2, SOLNA, 171 65, SWEDEN
Covered Properties (3)
Chimeric Il-1 Receptor Type I Agonists and Antagonists
Patent: 8,853,150 →
Application: 13/812,582 →
Publication: US 2013/0209396
Chimeric Il-1 Receptor Type I Agonists and Antagonists
Patent: 9,458,216 →
Application: 14/460,563 →
Publication: US 2015/0087818
Chimeric Cytokine Formulations for Ocular Delivery
Application: 15/670,840 →
Publication: US 2018/0177877
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 15, 2013
From: BARNES, THOMAS M.; HOU, JINZHAO; KING, BRACKEN M., MR.
To: ELEVEN BIOTHERAPEUTICS, INC.
Reel/Frame 031608/0984 →
Assignment of Assignor's Interest Sep 30, 2014
From: BARNES, THOMAS M.; HOU, JINZHAO; KING, BRACKEN M.
To: ELEVEN BIOTHERAPEUTICS, INC.
Reel/Frame 033847/0246 →
Change of Name May 27, 2020
From: ELEVEN BIOTHERAPEUTICS, INC.
To: SESEN BIO, INC.
Reel/Frame 052758/0304 →
Assignment of Assignor's Interest May 27, 2020
From: ZARBIS-PAPASTOITSIS, GREGORY; LOWDEN, PATRICIA
To: ELEVEN BIOTHERAPEUTICS, INC.
Reel/Frame 052758/0325 →
Assignment of Assignor's Interest May 27, 2020
From: CHANG, BYEONG
To: INTEGRITY BIO, INC.
Reel/Frame 052762/0546 →
Assignment of Assignor's Interest May 27, 2020
From: INTEGRITY BIO, INC.
To: ELEVEN BIOTHERAPEUTICS, INC.
Reel/Frame 052763/0057 →